Structural correlates underlying accelerated magnetic stimulation in Parkinson's disease

Gong‐Jun Ji,Tingting Liu,Ying Li,Pingping Liu,Jinmei Sun,Xingui Chen,Yanghua Tian,Xianwen Chen,Louisa Dahmani,Hesheng Liu,Kai Wang,Panpan Hu
DOI: https://doi.org/10.1002/hbm.25319
IF: 4.8
2020-12-14
Human Brain Mapping
Abstract:<p>Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive neuromodulation technique with great potential in the treatment of Parkinson's disease (PD). This study aimed to investigate the clinical efficacy of accelerated rTMS and to understand the underlying neural mechanism. In a double‐blinded way, a total of 42 patients with PD were randomized to receive real (<i>n</i> = 22) or sham (<i>n</i> = 20) continuous theta‐burst stimulation (cTBS) on the left supplementary motor area (SMA) for 14 consecutive days. Patients treated with real cTBS, but not with sham cTBS, showed a significant improvement in Part III of the Unified PD Rating Scale (<i>p</i> &lt; .0001). This improvement was observed as early as 1 week after the start of cTBS treatment, and maintained 8 weeks after the end of the treatment. These findings indicated that the treatment response was swift with a long‐lasting effect. Imaging analyses showed that volume of the left globus pallidus (GP) increased after cTBS treatment. Furthermore, the volume change of GP was mildly correlated with symptom improvement and associated with the baseline fractional anisotropy of SMA‐GP tracts. Together, these findings implicated that the accelerated cTBS could effectively alleviate motor symptoms of PD, maybe by modulating the motor circuitry involving the SMA‐GP pathway.</p>
radiology, nuclear medicine & medical imaging,neurosciences,neuroimaging
What problem does this paper attempt to address?
The main aim of this paper is to investigate the clinical effects of accelerated repetitive transcranial magnetic stimulation (rTMS) in the treatment of Parkinson's disease (PD) and to explore its potential neural mechanisms. Specifically, the objectives of the study include: 1. **Evaluate clinical efficacy**: Through a double-blind, randomized controlled trial, evaluate the effects of continuous theta-burst stimulation (cTBS) applied to the supplementary motor area (SMA) of the left hemisphere in Parkinson's disease patients. 2. **Explore neural mechanisms**: Using structural and functional magnetic resonance imaging techniques, investigate the association between the improvement of motor symptoms and brain structural changes in Parkinson's disease patients after cTBS treatment. The main findings of the study are as follows: - Parkinson's disease patients who received real cTBS treatment showed significant improvement in the Unified PD Rating Scale Part III (UPDRS-III) scores, while those who received sham cTBS treatment did not show significant changes. - This improvement could be observed as early as 1 week after the start of treatment and persisted for up to 8 weeks after the end of treatment. - MRI analysis showed an increase in the volume of the left hemisphere globus pallidus (GP) after cTBS treatment. - There was a slight correlation between the change in the volume of the left hemisphere GP and symptom improvement, which was also related to the fractional anisotropy (FA) of the SMA-GP pathway at baseline. In conclusion, this study demonstrates that accelerated cTBS can effectively alleviate motor symptoms in Parkinson's disease patients, possibly by modulating the motor circuits involving the SMA-GP pathway.